Titre : Hepatovirus

Hepatovirus : Questions médicales fréquentes

Termes MeSH sélectionnés :

Data Accuracy
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Hepatovirus : Questions médicales les plus fréquentes", "headline": "Hepatovirus : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Hepatovirus : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-31", "dateModified": "2025-03-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Hepatovirus" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Picornaviridae", "url": "https://questionsmedicales.fr/mesh/D010849", "about": { "@type": "MedicalCondition", "name": "Picornaviridae", "code": { "@type": "MedicalCode", "code": "D010849", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.820.578.750" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Virus de l'hépatite A", "alternateName": "Hepatitis A virus", "url": "https://questionsmedicales.fr/mesh/D030041", "about": { "@type": "MedicalCondition", "name": "Virus de l'hépatite A", "code": { "@type": "MedicalCode", "code": "D030041", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.820.578.750.400.410" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Virus de l'hépatite A humaine", "alternateName": "Hepatitis A Virus, Human", "url": "https://questionsmedicales.fr/mesh/D017957", "about": { "@type": "MedicalCondition", "name": "Virus de l'hépatite A humaine", "code": { "@type": "MedicalCode", "code": "D017957", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04.820.578.750.400.410.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Hepatovirus", "alternateName": "Hepatovirus", "code": { "@type": "MedicalCode", "code": "D006507", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Stanley M Lemon", "url": "https://questionsmedicales.fr/author/Stanley%20M%20Lemon", "affiliation": { "@type": "Organization", "name": "Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, United States." } }, { "@type": "Person", "name": "Olga González-López", "url": "https://questionsmedicales.fr/author/Olga%20Gonz%C3%A1lez-L%C3%B3pez", "affiliation": { "@type": "Organization", "name": "Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, United States." } }, { "@type": "Person", "name": "Hui Feng", "url": "https://questionsmedicales.fr/author/Hui%20Feng", "affiliation": { "@type": "Organization", "name": "Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA." } }, { "@type": "Person", "name": "Takayoshi Shirasaki", "url": "https://questionsmedicales.fr/author/Takayoshi%20Shirasaki", "affiliation": { "@type": "Organization", "name": "Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA." } }, { "@type": "Person", "name": "Kevin L McKnight", "url": "https://questionsmedicales.fr/author/Kevin%20L%20McKnight", "affiliation": { "@type": "Organization", "name": "Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hillgrid.10698.36, Chapel Hill, North Carolina, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Excellent agreement of Norwegian trauma registry data compared to corresponding data in electronic patient records.", "datePublished": "2023-09-26", "url": "https://questionsmedicales.fr/article/37752614", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13049-023-01118-5" } }, { "@type": "ScholarlyArticle", "name": "Assessment of immunization data management practices in Cameroon: unveiling potential barriers to immunization data quality.", "datePublished": "2023-09-27", "url": "https://questionsmedicales.fr/article/37759205", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12913-023-09965-9" } }, { "@type": "ScholarlyArticle", "name": "Mdwgan-gp: data augmentation for gene expression data based on multiple discriminator WGAN-GP.", "datePublished": "2023-11-13", "url": "https://questionsmedicales.fr/article/37957576", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12859-023-05558-9" } }, { "@type": "ScholarlyArticle", "name": "Thirty-three myths and misconceptions about population data: from data capture and processing to linkage.", "datePublished": "2023-01-31", "url": "https://questionsmedicales.fr/article/37636835", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.23889/ijpds.v8i1.2115" } }, { "@type": "ScholarlyArticle", "name": "Accuracy of ethnicity records at primary and secondary healthcare services in Waikato region, Aotearoa New Zealand.", "datePublished": "2024-09-06", "url": "https://questionsmedicales.fr/article/39236329", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.26635/6965.6445" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Virus", "item": "https://questionsmedicales.fr/mesh/D014780" }, { "@type": "ListItem", "position": 3, "name": "Virus à ARN", "item": "https://questionsmedicales.fr/mesh/D012328" }, { "@type": "ListItem", "position": 4, "name": "Virus à ARN à brin positif", "item": "https://questionsmedicales.fr/mesh/D000085102" }, { "@type": "ListItem", "position": 5, "name": "Picornaviridae", "item": "https://questionsmedicales.fr/mesh/D010849" }, { "@type": "ListItem", "position": 6, "name": "Hepatovirus", "item": "https://questionsmedicales.fr/mesh/D006507" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Hepatovirus - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Hepatovirus", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Hepatovirus", "description": "Comment diagnostiquer une infection par Hépatovirus ?\nQuels tests sont utilisés pour l'Hépatovirus ?\nQuels symptômes indiquent une hépatite virale ?\nPeut-on diagnostiquer l'Hépatovirus par imagerie ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D006507?mesh_terms=Data+Accuracy&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Hepatovirus", "description": "Quels sont les symptômes courants de l'hépatite A ?\nL'hépatite A provoque-t-elle des douleurs abdominales ?\nLes symptômes de l'hépatite A apparaissent-ils rapidement ?\nPeut-on avoir l'hépatite A sans symptômes ?\nQuels signes indiquent une forme sévère d'hépatite A ?", "url": "https://questionsmedicales.fr/mesh/D006507?mesh_terms=Data+Accuracy&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Hepatovirus", "description": "Comment prévenir l'hépatite A ?\nLe vaccin contre l'hépatite A est-il sûr ?\nQuelles pratiques d'hygiène sont recommandées ?\nLes aliments peuvent-ils transmettre l'hépatite A ?\nLes voyageurs doivent-ils se faire vacciner ?", "url": "https://questionsmedicales.fr/mesh/D006507?mesh_terms=Data+Accuracy&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Hepatovirus", "description": "Quel est le traitement de l'hépatite A ?\nLes antibiotiques sont-ils efficaces contre l'hépatite A ?\nFaut-il hospitaliser un patient atteint d'hépatite A ?\nComment soulager les symptômes de l'hépatite A ?\nY a-t-il des traitements préventifs pour l'hépatite A ?", "url": "https://questionsmedicales.fr/mesh/D006507?mesh_terms=Data+Accuracy&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Hepatovirus", "description": "Quelles sont les complications possibles de l'hépatite A ?\nL'hépatite A peut-elle causer des problèmes à long terme ?\nQuels facteurs augmentent le risque de complications ?\nComment surveiller les complications de l'hépatite A ?\nLes complications de l'hépatite A sont-elles fréquentes ?", "url": "https://questionsmedicales.fr/mesh/D006507?mesh_terms=Data+Accuracy&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Hepatovirus", "description": "Qui est le plus à risque d'hépatite A ?\nLes enfants sont-ils plus à risque d'hépatite A ?\nLe sexe influence-t-il le risque d'hépatite A ?\nLes personnes avec des maladies hépatiques sont-elles à risque ?\nComment le mode de vie affecte-t-il le risque d'hépatite A ?", "url": "https://questionsmedicales.fr/mesh/D006507?mesh_terms=Data+Accuracy&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par Hépatovirus ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par des tests sanguins pour détecter les anticorps spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour l'Hépatovirus ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques et les tests PCR sont couramment utilisés pour le diagnostic." } }, { "@type": "Question", "name": "Quels symptômes indiquent une hépatite virale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, jaunisse, douleurs abdominales et perte d'appétit." } }, { "@type": "Question", "name": "Peut-on diagnostiquer l'Hépatovirus par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie peut aider à évaluer les dommages au foie, mais n'est pas spécifique." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les facteurs de risque et les expositions antérieures." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de l'hépatite A ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent fatigue, nausées, vomissements, et jaunisse." } }, { "@type": "Question", "name": "L'hépatite A provoque-t-elle des douleurs abdominales ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs abdominales, surtout dans la région du foie, sont fréquentes." } }, { "@type": "Question", "name": "Les symptômes de l'hépatite A apparaissent-ils rapidement ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent apparaître 2 à 6 semaines après l'exposition au virus." } }, { "@type": "Question", "name": "Peut-on avoir l'hépatite A sans symptômes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes, notamment les enfants, peuvent être asymptomatiques." } }, { "@type": "Question", "name": "Quels signes indiquent une forme sévère d'hépatite A ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une forme sévère peut se manifester par une jaunisse intense et des saignements." } }, { "@type": "Question", "name": "Comment prévenir l'hépatite A ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination, une bonne hygiène et l'évitement des aliments contaminés sont essentiels." } }, { "@type": "Question", "name": "Le vaccin contre l'hépatite A est-il sûr ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vaccin est sûr et efficace, recommandé pour les voyageurs et les groupes à risque." } }, { "@type": "Question", "name": "Quelles pratiques d'hygiène sont recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Se laver les mains régulièrement et éviter l'eau non potable sont des pratiques clés." } }, { "@type": "Question", "name": "Les aliments peuvent-ils transmettre l'hépatite A ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les aliments crus ou mal cuits, surtout les fruits de mer, peuvent transmettre le virus." } }, { "@type": "Question", "name": "Les voyageurs doivent-ils se faire vacciner ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la vaccination est recommandée pour les voyageurs vers des zones à risque." } }, { "@type": "Question", "name": "Quel est le traitement de l'hépatite A ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement antiviral spécifique ; le repos et l'hydratation sont recommandés." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils efficaces contre l'hépatite A ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales comme l'hépatite A." } }, { "@type": "Question", "name": "Faut-il hospitaliser un patient atteint d'hépatite A ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "L'hospitalisation est rare, sauf en cas de complications sévères ou déshydratation." } }, { "@type": "Question", "name": "Comment soulager les symptômes de l'hépatite A ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments en vente libre peuvent aider à soulager la douleur et la fièvre." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs pour l'hépatite A ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vaccin contre l'hépatite A est très efficace pour prévenir l'infection." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de l'hépatite A ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance hépatique et des troubles de la coagulation." } }, { "@type": "Question", "name": "L'hépatite A peut-elle causer des problèmes à long terme ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "La plupart des personnes guérissent complètement sans séquelles à long terme." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées et celles avec des maladies hépatiques préexistantes sont à risque." } }, { "@type": "Question", "name": "Comment surveiller les complications de l'hépatite A ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical régulier est essentiel pour détecter les complications précoces." } }, { "@type": "Question", "name": "Les complications de l'hépatite A sont-elles fréquentes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les complications graves sont rares, mais peuvent survenir chez les personnes vulnérables." } }, { "@type": "Question", "name": "Qui est le plus à risque d'hépatite A ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes non vaccinées, les voyageurs et ceux en contact avec des cas sont à risque." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque d'hépatite A ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent être asymptomatiques, mais ils peuvent transmettre le virus." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque d'hépatite A ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Non, le risque d'hépatite A est similaire chez les hommes et les femmes." } }, { "@type": "Question", "name": "Les personnes avec des maladies hépatiques sont-elles à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont plus susceptibles de développer des complications graves." } }, { "@type": "Question", "name": "Comment le mode de vie affecte-t-il le risque d'hépatite A ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie avec des pratiques d'hygiène insuffisantes augmente le risque d'infection." } } ] } ] }

Sources (10000 au total)

Excellent agreement of Norwegian trauma registry data compared to corresponding data in electronic patient records.

The Norwegian Trauma Registry (NTR) is designed to monitor and improve the quality and outcome of trauma care delivered by Norwegian trauma hospitals. Patient care is evaluated through specific qualit... We validated 49 of the 118 variables registered in the NTR by comparing those with the corresponding ones in electronic patient records for 180 patients with a trauma diagnosis admitted in 2019 at eig... Almost perfect agreement (AC... All tested variables in the Norwegian Trauma Registry displayed excellent agreement with the corresponding variables in electronic patient records. Variables in the registry that showed missing data n...

Assessment of immunization data management practices in Cameroon: unveiling potential barriers to immunization data quality.

One crucial obstacle to attaining universal immunization coverage in Sub-Saharan Africa is the paucity of timely and high-quality data. This challenge, in part, stems from the fact that many frontline... A descriptive cross-sectional study was conducted, involving health districts and health facilities in all 10 regions in Cameroon selected by a multi-stage sampling scheme. Structured questionnaires a... A total of 265 facilities in 68 health districts were assessed. There was limited availability of some data recording tools like vaccination cards (43%), maintenance registers (8%), and stock cards (5... Our findings unveil important gaps in data collection practices at the facility level that could adversely affect Cameroon's immunization data quality. It highlights the urgent need for systematic cap...

Mdwgan-gp: data augmentation for gene expression data based on multiple discriminator WGAN-GP.

Although gene expression data play significant roles in biological and medical studies, their applications are hampered due to the difficulty and high expenses of gathering them through biological exp... In this study, an improved data augmentation approach MDWGAN-GP, a generative adversarial network model with multiple discriminators, is proposed. In addition, a novel method is devised for enriching ... The experimental results have demonstrated that compared with other state-of-the-art methods, the MDWGAN-GP method can produce higher quality generated gene expression data in most cases....

Accuracy of ethnicity records at primary and secondary healthcare services in Waikato region, Aotearoa New Zealand.

Ethnicity is an important variable, and in Aotearoa New Zealand it is used to monitor population health needs, health services outcomes and to allocate resources. However, there is a history of underc... Through individual record linkage, prospective self-reported ethnicity, collected using New Zealand Census and Ministry of Health - Manatū Hauora ethnicity protocol as a "gold standard", was compared ... Māori were undercounted in secondary NHI (32.5%) and primary care (31.3%) datasets compared to self-reported (34.6%). Between 9.5-11% of individuals had a different ethnicity recorded in health datase... Routine health datasets fail to adequately collect ethnicity, particularly for those with multiple ethnicities. Inaccuracies disproportionately affect Māori and urgent efforts are needed to improve co...

Drivers and Barriers to Improved Data Quality and Data-Use Practices: An Interpretative Qualitative Study in Addis Ababa, Ethiopia.

An objective of the Information Revolution Roadmap of Ethiopia's Health Sector Transformation Plan was to improve health management information system (HMIS) data quality and data use at the point of ... We conducted an interpretative qualitative study across all 11 health centers in 3 subcities of Addis Ababa, Ethiopia: Yeka, Akaki-Kaliti, and Ledeta. A total of 40 key informant interviews and 6 focu... Our findings indicate that the main drivers of data quality and use at the point of service delivery were the use of the Connected Woreda strategy and its tools, capacity-building activities including... Improvements in quality and use of HMIS data at health facilities are expected to result in delivering better-quality health services to the community as data enable health workers to identify gaps in...

Validation of Multi-State EHR-Based Network for Disease Surveillance (MENDS) Data and Implications for Improving Data Quality and Representativeness.

Surveillance modernization efforts emphasize the potential use of electronic health record (EHR) data to inform public health surveillance and prevention. However, EHR data streams vary widely in thei... We developed a validation process for the Multi-State EHR-Based Network for Disease Surveillance (MENDS) pilot project to identify and resolve data quality issues that could affect chronic disease pre... We identified gaps in the EHR databases of data contributors and in the processes to extract, map, integrate, and analyze their EHR data. Examples of source-data problems included missing data on race... Validation protocols identified critical errors in both EHR source data and in the processes used to transform these data for analysis. Our experience highlights the value and importance of data valid...

Optimizing data integration in trials that use EHR data: lessons learned from a multi-center randomized clinical trial.

Despite great promise, trials that ascertain patient clinical data from electronic health records (EHR), referred to here as "EHR-sourced" trials, are limited by uncertainty about how existing trial s... We describe a demonstration project that used EHR data to complement data collected for a contemporary multi-center pharmaceutical industry outcomes trial, and how a central coordinating center suppor... While broadening the type of sites able to participate in EHR-sourced trials may lead to greater generalizability and improved enrollment, sites with fewer technical resources may require additional s...